“Safety and immunogenicity of an AMA1 malaria vaccine in Malian children: results of a phase 1 randomized controlled trial.”, PLoS One, vol. 5, no. 2, p. e9041, 2010.
, “A Field Trial to Assess a Blood-Stage Malaria Vaccine”, N Engl J Med, vol. 365, pp. 1004-1013, 2011.
, “A field trial to assess a blood-stage malaria vaccine.”, N Engl J Med, vol. 365, no. 11, pp. 1004-13, 2011.
, “Late outgrowth endothelial progenitor cells in patients with age-related macular degeneration.”, Invest Ophthalmol Vis Sci, vol. 49, no. 6, pp. 2696-708, 2008.
, “Late Outgrowth Endothelial Progenitor Cells in Patients with Age-Related Macular Degeneration”, Invest Ophthalmol Vis Sci, vol. 49, pp. 2696-2708, 2008.
, “The effects of liver directed radiotherapy and chemotherapy on liver function tests and hematological parameters in patients with surgically resected colon cancer: findings from the Gastrointestinal Tumor Study Group.”, Am J Gastroenterol, vol. 82, no. 8, pp. 738-43, 1987.
, “Perineal effects of postoperative treatment for adenocarcinoma of the rectum.”, Int J Radiat Oncol Biol Phys, vol. 12, no. 2, pp. 167-71, 1986.
, “Toxicity associated with adjuvant postoperative therapy for adenocarcinoma of the rectum.”, Cancer, vol. 57, no. 6, pp. 1130-4, 1986.
, “Imputation using Longitudinal Data in Interval-Censored Survival Data”. Fort Collins, CO, 2010.
, “The safety and efficacy of chicken type II collagen on uveitis associated with juvenile rheumatoid arthritis.”, Ocul Immunol Inflamm, vol. 10, no. 2, pp. 83-91, 2002.
, “The safety and efficacy of chicken type II collagen on uveitis associated with juvenile rheumatoid arthritis”, Ocular Immunology & Inflammation, vol. 10, pp. 83-91, 2002.
, “A pilot study of dentists' assessment of caries detection and staging systems applied to early caries: PEARL Network findings.”, Gen Dent, vol. 64, no. 3, pp. 20-7, 2016.
, “Population Pharmacokinetics of Doxycycline in Children.”, Antimicrob Agents Chemother, 2019.
, “Joint Models”, in Encyclopedia of Environmetrics, 2ndnd ed., Chichester, UK: John Wiley & Sons, Ltd., 2012, pp. 1405-1408.
, “Risk for Major Hemorrhages in Patients Receiving Clopidogrel and Aspirin Compared With Aspirin Alone After Transient Ischemic Attack or Minor Ischemic Stroke: A Secondary Analysis of the POINT Randomized Clinical Trial.”, JAMA Neurol, vol. 76, no. 7, pp. 774-782, 2019.
, “Association of Dietary and Supplementary Calcium Intake With Age-Related Macular Degeneration: Age-Related Eye Disease Study Report 39.”, JAMA Ophthalmol, vol. 137, no. 5, pp. 543-550, 2019.
, “Islet Cell Transplantation in Type 1 Diabetes: An Analysis of Clinical Outcomes in Data from the Collaborative Islet Transplant Registry (CITR)”, in The 2012 Joint Statistical Meetings, San Diego, CA, 2012.
, “Islet Cell Transplantation in Type 1 Diabetes: An Analysis of Efficacy Outcomes and Considerations for Trial Designs”, Am J Transplant, vol. 12, pp. 1898-1907, 2012.
, “Islet cell transplantation in type 1 diabetes: an analysis of efficacy outcomes and considerations for trial designs.”, Am J Transplant, vol. 12, no. 7, pp. 1898-907, 2012.
, “Clinical trials referral resource. Current clinical trials of G3139.”, Oncology (Williston Park), vol. 17, no. 9, pp. 1244-6, 1251-3, 1258, 2003.
, “Updated Standardized Definitions for Efficacy End Points (STEEP) in Adjuvant Breast Cancer Clinical Trials: STEEP Version 2.0.”, J Clin Oncol, p. JCO2003613, 2021.
, “Fludarabine-based conditioning for marrow transplantation from unrelated donors in severe aplastic anemia: early results of a cyclophosphamide dose deescalation study show life-threatening adverse events at predefined cyclophosphamide dose levels.”, Biol Blood Marrow Transplant, vol. 18, no. 7, pp. 1007-11, 2012.
, “Fludarabine-Based Conditioning for Marrow Transplantation From Unrelated Donors in Severe Aplastic Anemia: Early Results of a Cyclophosphamide Dose De-Escalation Study Show Life-Threatening Adverse Events at Predefined Cyclophosphamide Dose Levels”, Biol Blood Marrow Transplant, vol. 18, pp. 1007-1011, 2012.
, “Autologous vs. Reduced Intensity Allogeneic Hematopoietic Cell Transplantation for Patients with Chemosensitive Follicular Non-Hodgkin's Lymphoma Beyond First Complete Response or First Partial Response”, Biol Blood Marrow Transplant, vol. 17, pp. 1051-1057, 2011.
, “Autologous versus reduced-intensity allogeneic hematopoietic cell transplantation for patients with chemosensitive follicular non-Hodgkin lymphoma beyond first complete response or first partial response.”, Biol Blood Marrow Transplant, vol. 17, no. 7, pp. 1051-7, 2011.
,